(19)
(11) EP 2 057 158 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.09.2015 Bulletin 2015/40

(45) Mention of the grant of the patent:
12.08.2015 Bulletin 2015/33

(21) Application number: 07803060.8

(22) Date of filing: 30.08.2007
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61P 29/00(2006.01)
A61P 35/00(2006.01)
A61K 31/437(2006.01)
A61P 37/00(2006.01)
(86) International application number:
PCT/EP2007/059051
(87) International publication number:
WO 2008/025821 (06.03.2008 Gazette 2008/10)

(54)

TRIAZOLE DERIVATIVES AS KINASE INHIBITORS

TRIAZOLDERIVATE ALS KINASEINHIBITOREN

DÉRIVÉS DE TRIAZOLE EN TANT QU'INHIBITEURS DE KINASE


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 30.08.2006 EP 06119831
23.05.2007 EP 07108769

(43) Date of publication of application:
13.05.2009 Bulletin 2009/20

(73) Proprietor: Cellzome Limited
Brentford, Middlesex TW8 9GS (GB)

(72) Inventors:
  • WILSON, Francis
    Herts Hertfordshire AL 7 AQJ (GB)
  • RAMSDEN, Nigel
    Royston, Herts Hertfordshire SG8 7QP (GB)
  • BELL, Kathryn
    London London EC1R 5HP (GB)
  • CANSFIELD, Andrew
    Harston Cambridgeshire CB22 7QT (GB)
  • BURCKHARDT, Svenja
    Newmarket CB8 9QG (GB)
  • TAYLOR, Jess
    Stotfold, Hitchin Hertfordshire SG5 4PJ (GB)
  • SUNOSE, Mihiro
    Pampisford Cambridgeshire CB22 3EW (GB)
  • MIDDLEMISS, David
    Bishops Stortford Hertfordshire CM23 33NF (GB)

(74) Representative: Shore, Andrew David 
GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)


(56) References cited: : 
WO-A-03/010167
WO-A1-96/31517
WO-A2-2006/018735
WO-A-2004/072072
WO-A1-2007/095588
WO-A2-2006/038116
   
  • NETTEKOVEN, MATTHIAS ET AL: "Synthetic access to 2-amido-5-aryl-8-methoxy-triazolopyridine and 2-amido-5-morpholino-8-methoxy-triazolopyr idine derivatives as potential inhibitors of the adenosine receptor subtypes" SYNTHESIS , (11), 1649-1652 CODEN: SYNTBF; ISSN: 0039-7881, 2003, XP002416826
  • YAMAZAKI, CHIJI ET AL: "Cyclization of isothiosemicarbazones. Part 10. A novel route to 2-amino[1,2,4]triazolo[1,5-a]pyridine derivatives" JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY (1972-1999) , (7), 825-8 CODEN: JCPRB4; ISSN: 0300-922X, 1994, XP002416827
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).